JPRN-UMIN000019337已完成未知
ow-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors - methotrexate and vinblastine for patients with desmoid tumors
agoya University Hospital0 个研究点目标入组 20 人开始时间: 2015年10月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •not tolerated to chemotherapy
研究者
相似试验
招募中
1 期
chemotherapy for aggressive desmoid tumorJPRN-jRCTs041180009Hayashi Katsuhiro6
已完成
不适用
Combination chemotherapy with methotrexate and vinblastine for surgically unresectable, aggressive desmoid tumordesmoid tumorJPRN-UMIN000030998Kanazawa University Hospital6
进行中（未招募）
不适用
Intensified methotrexate, vinblastine, doxorubicin and cisplatin (I-MVAC) with or without panitumumab as first-line treatment of advanced urothelial carcinoma in patients without H-Ras nor K-Ras mutations. Randomised phase II study.Advanced urothelial carcinoma in patients without H-Ras nor K-Ras mutationsMedDRA version: 12.1Level: LLTClassification code 10046714Term: Urothelial carcinoma bladderEUCTR2009-011882-10-FRFNCLCC (Fédération Nationale des Centres de Lutte Contre le Cancer)
已完成
3 期
Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the UrotheliumTransitional Cell Cancer of the Renal Pelvis and UreterBladder CancerUrethral CancerNCT00003376Eastern Cooperative Oncology Group330
已完成
2 期
Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma (PRIMAIN)primär cerebrales LymphomDRKS00000582niversitätsklinikum Freiburg- vertreten durch:Leitenden Ärztlichen Direktor112